Glioblastoma Clinical Trials in Kansas City, MO

Glioblastoma Clinical Trials in Kansas City, MO

View the best 10 glioblastoma medical studies in Kansas City, Missouri. Access promising new therapies by applying to a Kansas City-based Glioblastoma clinical trial.

Top rated glioblastoma clinical trials in Kansas City, Missouri

Here are the top 9 medical studies for glioblastoma in Kansas City, Missouri

Michael Bask Gill, B Sc preview

Michael Bask Gill, B Sc

Last Reviewed: April 22nd, 2024

Image of UC Irvine Health Cancer Center-Newport in Costa Mesa, United States.

Olaparib

PARP Inhibitor

Recruiting1 awardPhase 2
This trial will study how well olaparib works in treating patients with certain types of cancer that have spread and usually cannot be controlled with treatment. Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Image of 1004 in Denver, United States.

BDTX-1535

Small Molecule Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug for people with glioblastoma or non-small cell lung cancer who have disease progression following standard of care.
Image of Phoenix Childrens Hospital in Phoenix, United States.

Radiation Therapy

Radiation

Recruiting1 awardPhase 2
This trial studies how well a combination of dabrafenib and trametinib works after radiation therapy in children and young adults with high grade glioma who have a genetic change called BRAF V600 mutation.
Image of Barrow Neurological Institute in Phoenix, United States.

Berubicin +1 More

Anthracenedione

Recruiting1 awardPhase 2
This trial will compare the effect of two cancer drugs, berubicin and lomustine, on overall survival in patients with glioblastoma multiforme (GBM) who have failed standard first line therapy. A futility analysis will be performed after approximately 30-50% of planned patients have completed the primary endpoint at 6 months.
Image of Banner MD Anderson in Gilbert, United States.

APL-101

Small Molecule Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug to see if it is safe and effective for people with different types of cancer.
Image of Grandview Cancer Center in Birmingham, United States.

OptuneĀ®

Device

Recruiting1 award12 criteria
This trial is testing a new treatment for brain cancer that combines Optune with radiation and chemotherapy. The goal is to see if this new combination is more effective and has fewer side effects than current treatments.
Image of University of Kansas Medical Center in Olathe, United States.

TVI-Brain-1 +2 More

CAR T-cell Therapy

Recruiting1 awardPhase 2 & 3
This trial will study an immunotherapy combining a cancer-patient's own cells and standard treatment to fight glioblastoma. Immune cells will be harvested from the patient, stimulated and expanded, then infused back.
Image of Vidant Health in Greenville, United States.

GammaTile radiation therapy implantation +3 More

Brachytherapy

Recruiting3 awardsPhase 4
This trial will assess the feasibility and tolerability of addingGammaTile radiation therapy as an upfront boost at the time of maximum safe resection, along with the backbone of the current standard of care approach, concomitant and adjuvant temozolomide +/- TTF, for patients with newly diagnosed GBM.
Image of Kaiser Permanente Los Angeles Medical Center in Los Angeles, United States.

Ramipril

ACE Inhibitor

Recruiting1 awardPhase 2
This trial is testing whether Ramipril can help cancer patients undergoing chemoradiation treatment by reducing memory loss. Patients will take the drug throughout treatment and for four months after. Memory will be assessed using neurocognitive tests.

Popular filter options for glioblastoma kansas-city trials

Age 65+
Phase 3
< 50 mile distance
No Placebo

Clinical Trials With No Placebo

View 20 medical studies that do not have a placebo group.

Phoenix, Arizona

Radiation

Dabrafenib + Trametinib After Radiation for Brain Cancer

Recruiting1 awardPhase 2
Kansas City, Missouri
This trial studies how well a combination of dabrafenib and trametinib works after radiation therapy in children and young adults with high grade glioma who have a genetic change called BRAF V600 mutation.
Birmingham, Alabama

PARP Inhibitor

Veliparib + Radiation + Temozolomide for Brain Cancer

Recruiting1 awardPhase 2
Kansas City, Missouri
This trial is studying a combination of drugs as a potential treatment for newly diagnosed malignant glioma. The drugs being studied are veliparib, radiation therapy, and temozolomide.
Birmingham, Alabama

CDK4/6 Inhibitor

Palbociclib for Advanced Solid Cancers and Non-Hodgkin Lymphoma

Recruiting1 awardPhase 2
Kansas City, Missouri
This trial studies how well palbociclib works in treating pediatric patients with Rb positive solid tumors, non-Hodgkin lymphoma, or histiocytic disorders.
Los Angeles, California

ACE Inhibitor

Ramipril for Memory Loss in Glioblastoma Patients

Recruiting1 awardPhase 2
Des Moines, Iowa
This trial is testing whether Ramipril can help cancer patients undergoing chemoradiation treatment by reducing memory loss. Patients will take the drug throughout treatment and for four months after. Memory will be assessed using neurocognitive tests.
Birmingham, Alabama

PARP Inhibitor

Olaparib for Cancer

Recruiting1 awardPhase 2
Kansas City, Missouri
This trial is testing how well olaparib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with defects in DNA damage repair genes.
Birmingham, Alabama

Kinase Inhibitor

Larotrectinib for Advanced Cancer

Recruiting1 awardPhase 2
Kansas City, Missouri
This trial is testing larotrectinib, which may stop the growth of cancer cells, in patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders that have spread and come back or do not respond to treatment.

View More Glioblastoma Kansas-city Trials

See another 6 medical studies focused on glioblastoma kansas-city.

Berubicin +1 More

Atezolizumab +1 More

OptuneĀ®

Selpercatinib

Tipifarnib

Ivosidenib

View more glioblastoma clinical trials kansas-city

See more medical studies focusing on glioblastoma kansas-city

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' ā€” so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back ā€” in general, verified trials respond to patients within a few days.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top